Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH)
Fisher & Paykel Healthcare announced today that it has expanded its operations in Asia with the establishment of a company in Japan, Fisher & Paykel Healthcare KK, and the opening of a sales and marketing support office in Tokyo.
Senior Vice President Sales and Marketing, Mr Paul Shearer, said today that Japan was the largest market in the Asia Pacific region for the company’s respiratory humidifier systems, and was expected to become a rapidly growing market for devices to treat obstructive sleep apnea (OSA).
The Asia Pacific region generated NZ$49 million of Fisher & Paykel Healthcare’s worldwide NZ$215 million revenue during the year ended 31 March 2004.
“We have a longstanding relationship in Japan with our distributor, Tokibo Co Ltd, and our new office will significantly increase our ability to provide Tokibo with support to continue to grow our business in Japan. Our initial team of two people will also provide marketing support to our ventilator OEM (Original Equipment Manufacturer) customers in Japan,” commented Mr Shearer.
Fisher & Paykel Healthcare has also recently expanded its presence in several important developing markets. This is in line with the company’s strategy to expand its sales activities worldwide to both encourage and support sales growth.
“In China we have expanded our marketing team based in Guangzhou and we have opened an office in Bangalore, to support our network of distributors in India. In the Middle East we have appointed a product specialist, based in Dubai,” added Mr Shearer.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of heated humidification products and systems for use in respiratory care and the treatment of obstructive sleep apnea. It also offers an innovative range of patient warming devices and neonatal care products. The company’s products are sold in over 90 countries worldwide.
Further information can be obtained by contacting CEO, Michael Daniell on +64 9 5740161 or Paul Shearer on +64 9 574 0167 at Fisher & Paykel Healthcare Corporation Limited or by visiting the company’s website at www.fphcare.com
Fisher & Paykel Healthcare Opens Office in Japan
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
This access is intended for health professionals only and by accessing it you agree to be a health professional.
I am a health professional. P>
Remember my choice